Back to URGN

Aisling Capital Management LP → URGN

Aisling Capital Management LP URGN Position History

UroGen Pharma Ltd. • Healthcare

Quarters held
4
Latest value
$4.4M
Q3 2026
Peak value
$4.4M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$2.5M
Q1 2026$1.9M
Q2 2026$4M
Q3 2026$4.4M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$4.4M108.0K——
Q2 2026$4M108.0K——
Q1 2026$1.9M108.0K——
Q4 2025$2.5M108.0K——

Other funds holding URGN

Other Aisling Capital Management LP positions

BBIO

BridgeBio Pharma Inc. (BBIO)

$389.3M
BBIO

BridgeBio Pharma Inc. (BBIO)

$378M
BBIO

BRIDGEBIO PHARMA INC

$341.8M
BBIO

BRIDGEBIO PHARMA INC

$203.3M
MNST

MONTE ROSA THERAPEUTICS INC

$37.6M
SNDX

Syndax Pharmaceuticals, Inc. (SNDX)

$30.8M
SNDX

SYNDAX PHARMACEUTICALS INC

$28.8M
SNDX

Syndax Pharmaceuticals, Inc. (SNDX)

$27.7M